Palliative care and end-of-life care in adults with malignant brain tumors
- PMID: 36271873
- PMCID: PMC10013651
- DOI: 10.1093/neuonc/noac216
Palliative care and end-of-life care in adults with malignant brain tumors
Erratum in
-
Corrigendum to: Palliative care and end-of-life care in adults with malignant brain tumors.Neuro Oncol. 2023 Jan 5;25(1):212. doi: 10.1093/neuonc/noac252. Neuro Oncol. 2023. PMID: 36610983 Free PMC article. No abstract available.
Abstract
Background: This systematic review provides updated insights, from the published literature in the past 5 years, based on the 2017 European Association of Neuro-Oncology (EANO) guidelines for palliative care in adults with malignant brain tumors. It provides an overview of palliative care options, including during the end-of-life phase for patients with malignant brain tumors.
Methods: A systematic literature search was conducted from 2016 to 2021 focusing on four main topics: (1) symptom management, (2) caregiver needs, (3) early palliative care, and (4) care in the end-of-life phase. An international panel of palliative care experts in neuro-oncology synthesized the literature and reported the most relevant updates. A total of 140 articles were included.
Results: New insights include that: Hippocampal avoidance and stereotactic radiosurgery results in a lower risk of neurocognitive decline in patients with brain metastases; levetiracetam is more efficacious in reducing seizures than valproic acid as first-line monotherapy antiseizure drug (ASD) in glioma patients; lacosamide and perampanel seem well-tolerated and efficacious add-on ASDs; and a comprehensive framework of palliative and supportive care for high-grade glioma patients and their caregivers was proposed. No pharmacological agents have been shown in randomized controlled trials to significantly improve fatigue or neurocognition.
Conclusions: Since the 2017 EANO palliative care guidelines, new insights have been reported regarding symptom management and end-of-life care, however, most recommendations remain unchanged. Early palliative care interventions are essential to define goals of care and minimize symptom burden in a timely fashion. Interventional studies that address pain, fatigue, and psychiatric symptoms as well as (the timing of) early palliative care are urgently needed.
Keywords: brain metastases; brain tumor; end of life; glioma; palliative care.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Advances in palliative care in neuro-oncology come in many forms.Neuro Oncol. 2023 Mar 14;25(3):457-458. doi: 10.1093/neuonc/noac287. Neuro Oncol. 2023. PMID: 36610079 Free PMC article. No abstract available.
-
Letter regarding "Palliative care and end-of-life care in adults with malignant brain tumors".Neuro Oncol. 2023 Mar 14;25(3):612-613. doi: 10.1093/neuonc/noad006. Neuro Oncol. 2023. PMID: 36801954 Free PMC article. No abstract available.
-
Reply to the letter regarding "Palliative care and end-of-life care in adults with malignant brain tumors".Neuro Oncol. 2023 Jul 6;25(7):1377-1378. doi: 10.1093/neuonc/noad069. Neuro Oncol. 2023. PMID: 37098001 Free PMC article. No abstract available.
References
-
- Temel JS, Greer JA, Muzikansky A, et al. . Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010; 363(8):733–742. - PubMed
-
- Pace A, Dirven L, Koekkoek JAF, et al. . European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol. 2017; 18(6):e330–e340. - PubMed
-
- Ng JCH, See AAQ, Ang TY, et al. . Effects of surgery on neurocognitive function in patients with glioma: a meta-analysis of immediate post-operative and long-term follow-up neurocognitive outcomes. J Neurooncol. 2019; 141(1):167–182. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous